Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: Biojunkie who wrote (638)	4/9/1998 12:02:00 AM
From: Druss	Respond to of 4634

Biojunkie--I have been reading what you have said. Perhaps you could tell me why this compound is considered a HIV treatment and not a treatment for other retroviruses and such things as the common cold, ebola, influenza, rabies, and so forth. HIV seems to me to be a very limited area of response, why just HIV? All the Best Druss

To: Biojunkie who wrote (638)	4/9/1998 1:00:00 AM
From: Bill Wexler	Read Replies (1) \| Respond to of 4634

Really? It screams "SCAM" to me.

To: Biojunkie who wrote (638)	4/9/1998 9:00:00 AM
From: Hank	Read Replies (1) \| Respond to of 4634

"...key hormones in the body or anologs of those hormones may inhibit cellular factors required by the virus to replicate." There are certainly enzymes and other naturally occurring co-factors in the body that are necessary for HIV replication. The problem is that they are also needed for normal cell growth. If you start trying to inhibit these cellular functions by disrupting the natural hormonal balance of the body, you will undoubtedly have numerous serious side effects to contend with, possibly including but not limited to DEATH. Drugs designed to inhibit natural cellular factors are notoriously toxic for this reason. That is why all major efforts involving HIV to date have focused on specific VIRAL targets.